Tumor cell vasculogenic mimicry: From controversy to therapeutic promise

American Journal of Pathology

Volumn 181, Issue 4, 2012, Pages 1115-1125

  Seftor, Richard E B ^a,b   Hess, Angela R ^c   Seftor, Elisabeth A ^a,b   Kirschmann, Dawn A ^a,b   Hardy, Katharine M ^a,b   Margaryan, Naira V ^a   Hendrix, Mary J C ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BLOOMSBURG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; CURCUMIN; ERLOTINIB; FUMAGILLOL CHLOROACETYLCARBAMATE; GEFITINIB; IMATINIB; ISOXANTHOHUMOL; LAPATINIB; PANITUMUMAB; PAZOPANIB; RAPAMYCIN; RECOMBINANT ENDOSTATIN; RESVERATROL; SORAFENIB; SUNITINIB; THALIDOMIDE; VADIMEZAN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ASTROCYTOMA; BLADDER CARCINOMA; BREAST CARCINOMA; CANCER STEM CELL; EWING SARCOMA; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HYPOXIA; KIDNEY CARCINOMA; LUNG CARCINOMA; MELANOMA; NONHUMAN; OSTEOSARCOMA; OVARY CARCINOMA; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR CELL VASCULOGENIC MIMICRY; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 84866524036     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.07.013     Document Type: Article

References (69)

1. A.J. Maniotis, R. Folberg, A. Hess, E.A. Seftor, L.M.G. Gardner, J. Pe'er, J.M. Trent, P.S. Meltzer, M.J.C. Hendrix Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry Am J Pathol 155 1999 739 752 (Pubitemid 29426820)
2. M.J. Bissell Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch A rose by any other name? Am J Pathol 155 1999 675 679 (Pubitemid 29426811)
3. M. Barinaga New type of blood vessel found in tumors Science 285 1999 1475
4. D.M. McDonald, L. Munn, R.K. Jain Vasculogenic mimicry: how convincing, how novel, and how significant Am J Pathol 156 2000 383 388
5. M.J.C. Hendrix, E.A. Seftor, A.R. Hess, R.E.B. Seftor Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma Nat Rev Cancer 3 2003 411 421 (Pubitemid 37328845)
6. A.K. Sood, E.A. Seftor, M.S. Fletcher, L.M.G. Gardner, P.M. Heidger, R.E. Butler, R.E.B. Seftor, M.J.C. Hendrix Molecular determinants of ovarian cancer plasticity Am J Pathol 158 2001 1279 1288 (Pubitemid 32281292)
7. R.E.B. Seftor, E.A. Seftor, N. Koshikawa, P.S. Meltzer, L.M.G. Gardner, M. Bilban, W.G. Stetler-Stevenson, V. Quaranta, M.J.C. Hendrix Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma Cancer Res 61 2001 6322 6327 (Pubitemid 32783230)
8. A.R. Hess, E.A. Seftor, L.M. Gruman, M.S. Kinch, R.E.B. Seftor, M.J.C. Hendrix VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry Cancer Biol Ther 5 2006 228 233 (Pubitemid 43327544)
9. B.A. Warren, P. Shubik The growth of the blood supply to melanoma transplants in the hamster cheek pouch Lab Invest 15 1966 464 478
10. C.H. Damsky, S.J. Fisher Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors Curr Opin Cell Biol 10 1998 660 666 (Pubitemid 28477026)
11. Y.W.J. Paulis, P.M. Soetekouw, H.M.W. Verheul, V.C.G. Tjan-Heijnen, A.W. Griffioen Signalling pathways in vasculogenic mimicry Biochim Biophys Acta 1806 2010 18 28
12. B. Döme, M.J.C. Hendrix, S. Paku, J. Tovari, J. Timar Alternative vascularization mechanisms in cancer: pathology and therapeutic implications Am J Pathol 170 2007 1 15 (Pubitemid 47339184)
13. L. Ricci-Vitiani, R. Pallini, M. Biffoni, M. Todaro, G. Invernici, T. Cenci, G. Maira, E.A. Parati, G. Stassi, L.M. Larocca, R. De Maria Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells [Erratum appeared in Nature 2011, 477:238, and in Nature 2011, 469:432] Nature 468 2010 824 828
14. R. Wang, K. Chadalavada, J. Wilshire, U. Kowalik, K.E. Hovinga, A. Gever, B. Fligelman, M. Leversha, C. Brennan, V. Tabar Glioblastoma stem-like cells give rise to tumour endothelium Nature 468 2010 829 833
15. M. Bittner, P. Meltzer, Y. Chen, Y. Jiang, E.A. Seftor, M.J.C. Hendrix, M. Radmacher, R. Simon, Z. Yakhini, A. Ben-Dor, N. Sampas, E. Dougherty, E. Wang, F. Marincola, C. Gooden, J. Lueders, A. Glatfelter, P. Pollock, J. Carpten, E. Gillanders, D. Leja, K. Dietrich, C. Beaudry, M. Berens, D. Alberts, V. Sondak Molecular classification of cutaneous malignant melanoma by gene expression: shifting from a continuous spectrum to distinct biologic entries Nature 406 2000 536 540 (Pubitemid 30625740)
16. Z. Demou, M.J.C. Hendrix Microgenomics profile of the endogenous angiogenic phenotype in subpopulations of aggressive melanoma J Cell Biochem 105 2008 562 573
17. L.M. Postovit, N.V. Margaryan, E.A. Seftor, D.A. Kirschmann, A. Lipavsky, W.W. Wheaton, D.E. Abbott, R.E.B. Seftor, M.J.C. Hendrix Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells Proc Nat Acad Sci USA 105 2008 4329 4334 (Pubitemid 351754380)
18. D. Mihic-Probst, K. Ikenberg, M. Tinguely, P. Schrami, S. Behnke, B. Seifert, G. Civenni, L. Sommer, H. Moch, R. Dummer Tumor cell plasticity and angiogenesis in human melanoma PLoS One 7 2012 e33571
19. M.J.C. Hendrix, E.A. Seftor, P.S. Meltzer, A.R. Hess, L.M. Gruman, B.J. Nickoloff, L. Miele, D.D. Sheriff, G.C. Schatteman, M.A. Bourdon, R.E.B. Seftor The stem cell plasticity of aggressive melanoma tumor cells S. Sell, Stem Cells Handbook 2000 Humana Press Totowa NJ 297 306
20. W. Ruf, E.A. Seftor, R.J. Petrovan, R.M. Weiss, L.M. Gruman, N.V. Margaryan, R.E.B. Seftor, Y. Miyagi, M.J.C. Hendrix Differential role of tissue factor pathway inhibitors 1 and 2 (TFPI-1 and 2) in melanoma vasculogenic mimicry Cancer Res 63 2003 5381 5389 (Pubitemid 37139855)
21. M.J.C. Hendrix, R.E.B. Seftor, E.A. Seftor, L.M. Gruman, L.M. Lee, B.J. Nickoloff, L. Miele, D.D. Sheriff, G.C. Schatteman Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination Cancer Res 62 2002 665 668 (Pubitemid 34126938)
22. D.A. Kirschmann, E.A. Seftor, K.M. Hardy, R.E.B. Seftor, M.J.C. Hendrix Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications Clin Cancer Res 18 2012 2726 2732
23. E.A. Seftor, P.S. Meltzer, G.C. Schatteman, L.M. Gruman, A.R. Hess, D.A. Kirschmann, R.E.B. Seftor, M.J.C. Hendrix Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry Crit Rev Oncol Hematol 44 2002 17 27 (Pubitemid 35175468)
24. M.J.C. Hendrix, E.A. Seftor, P.S. Meltzer, L.M. Gardner, A.R. Hess, D.A. Kirschmann, G.C. Schatteman, R.E.B. Seftor Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry Proc Natl Acad Sci USA 98 2001 8018 8023 (Pubitemid 32642679)
25. A.R. Hess, E.A. Seftor, L.M. Gardner, K. Carles-Kinch, G.B. Schneider, R.E.B. Seftor, M.S. Kinch, M.J.C. Hendrix Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2) Cancer Res 61 2001 3250 3255 (Pubitemid 32695007)
26. A.R. Hess, M.J.C. Hendrix Focal adhesion kinase signaling and the aggressive melanoma phenotype Cell Cycle 5 2006 478 480 (Pubitemid 43340521)
27. A.R. Hess, E.A. Seftor, R.E.B. Seftor, M.J.C. Hendrix Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry Cancer Res 63 2003 4757 4762 (Pubitemid 37022600)
28. T. Sun, N. Zhao, X.L. Zhao, Q. Gu, S.W. Zhang, N. Che, X.H. Wang, J. Du, Y.X. Liu, B.C. Sun Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry Hepatology 51 2010 545 556
29. A. Vartanian, E. Stepanova, I. Grigorieva, E. Solomko, A. Baryshnikov, M. Lichinitser VEGFR1 and PKCalpha signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner Melanoma Res 21 2011 91 98
30. S. Koch, S. Tugues, X. Li, L. Gualandi, L. Claesson-Welsh Signal transduction by vascular endothelial growth factor receptors Biochem J 437 2011 169 183
31. N.Y. Frank, T. Schatton, S. Kim, Q. Zhan, B.J. Wilson, J. Ma, K.R. Saab, V. Osherov, H.R. Widlund, M. Gasser, A.M. Waaga-Gasser, T.S. Kupper, G.F. Murphy, M.H. Frank VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth Cancer Res 71 2011 1474 1485
32. J.Y. Wang, T. Sun, X.L. Zhao, S.W. Zhang, D.F. Zhang, Q. Gu, X.H. Wang, N. Zhao, S. Qie, B.C. Sun Functional significance of VEGF-A in human ovarian carcinoma: role in vasculogenic mimicry Cancer Biol Ther 7 2008 758 766
33. N. Cheng, D. Brantley, W.B. Fang, H. Liu, W. Fanslow, D.P. Cerretti, K.N. Bussell, A. Reith, D. Jackson, J. Chen Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors Neoplasia 5 2003 445 456 (Pubitemid 37475653)
34. W.K. Wu, J.J. Sung, C.W. Lee, J. Yu, C.H. Cho Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms Cancer Lett 295 2010 7 16
35. G.D. Basu, W.S. Liang, D.A. Stephan, L.T. Wegener, C.R. Conley, B.A. Pockaj, P. Mukherjee A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells Breast Cancer Res 8 2006 R69
36. F.M. Robertson, A.M. Simeone, A. Lucci, J.S. McMurray, S. Ghosh, M. Cristofanilli Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4 Cancer 116 11 Suppl 2010 2806 2814
37. D. Hoshina, R. Abe, S.I. Yamagishi, H. Shimizu The role of PEDF in tumor growth and metastasis Curr Mol Med 10 2010 292 295
38. J.L. Orgaz, O. Ladhani, K.S. Hoek, A. Fernández-Barral, D. Mihic, O. Aguilera, E.A. Seftor, A. Bernad, J.L. Rodríguez-Peralto, M.J. Hendrix, O.V. Volpert, B. Jiménez Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma Oncogene 28 2009 4147 4161
39. L. Strizzi, K.M. Hardy, E.A. Seftor, F.F. Costa, D.A. Kirschmann, R.E.B. Seftor, L.M. Postovit, M.J.C. Hendrix Development and cancer: at the crossroads of Nodal and Notch signaling [Erratum appeared in Cancer Res 2009, 69:8526-7] Cancer Res 69 2009 7131 7134
40. K.M. Hardy, D.A. Kirschmann, E.A. Seftor, N.V. Margaryan, L.M. Postovit, L. Strizzi, M.J.C. Hendrix Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype Cancer Res 70 2010 10340 10350
41. A.F. Schier Nodal signaling in vertebrate development Annu Rev Cell Dev Biol 19 2003 589 621 (Pubitemid 37487362)
42. J.M. Topczewska, L.M. Postovit, N.V. Margaryan, A. Sam, A.R. Hess, W.W. Wheaton, B.J. Nickoloff, J. Topczewski, M.J.C. Hendrix Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness Nat Med 12 2006 925 932 (Pubitemid 44175144)
43. L. Strizzi, K.M. Hardy, D.A. Kirschmann, L. Ahrlund-Richter, M.J.C. Hendrix Nodal expression and detection in cancer: experience and challenges Cancer Res 72 2012 1915 1920
44. F.F. Costa, E.A. Seftor, J.M. Bischof, D.A. Kirschmann, L. Strizzi, K. Arndt, F. Bonaldo Mde, M.B. Soares, M.J.C. Hendrix Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment Epigenomics 1 2009 387 398
45. J.C. McAllister, Q. Zhan, C. Weishaupt, M.Y. Hsu, G.F. Murphy The embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts J Cutan Pathol 37 Suppl 1 2010 19 25
46. L. Strizzi, K.M. Hardy, N.V. Margaryan, D.W. Hillman, E.A. Seftor, B. Chen, X.J. Geiger, E.A. Thompson, W.L. Lingle, C.A. Andorfer, E.A. Perez, M.J.C. Hendrix Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer Breast Cancer Res 14 2012 R75
47. L. Strizzi, L.M. Postovit, N.V. Margaryan, A. Lipavsky, J. Gadiot, C. Blank, R.E.B. Seftor, E.A. Seftor, M.J.C. Hendrix Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention Expert Rev Dermatol 4 2009 67 78
48. J. Liu, C. Sato, M. Cerletti, A. Wagers Notch signaling in the regulation of stem cell self-renewal and differentiation Curr Top Dev Biol 92 2010 367 409
49. L.T. Krebs, N. Iwai, S. Nonaka, I.C. Welsh, Y. Lan, R. Jiang, Y. Saijoh, T.P. O'Brien, H. Hamada, T. Gridley Notch signaling regulates left-right asymmetry determination by inducing Nodal expression Genes Dev 17 2003 1207 1212 (Pubitemid 36583163)
50. A. Raya, Y. Kawakami, C. Rodriguez-Esteban, D. Buscher, C.M. Koth, T. Itoh, M. Morita, R.M. Raya, I. Dubova, J.G. Bessa, J.L. de la Pompa, J.C. Izpisua Belmonte Notch activity induces Nodal expression and mediates the establishment of left-right asymmetry in vertebrate embryos Genes Dev 17 2003 1213 1218 (Pubitemid 36583164)
51. K. De Bock, M. Mazzone, P. Carmeliet Antiantiogenic therapy, hypoxia, and metastasis: risky liaisons, or not Nat Rev Clin Oncol 8 2011 393 404
52. E. Benizri, A. Ginouvès, E. Berra The magic of the hypoxia-signaling cascade Cell Mol Life Sci 65 2008 1133 1149
53. A. Fernández-Barral, J.L. Orgaz, V. Gomez, L. del Peso, M.J. Calzada, B. Jiménez Hypoxia negatively regulates antimetastatic PEDF in melanoma cells by a hypoxia inducible factor-independent, autophagy dependent mechanisms PLoS One 7 2012 e32989
54. G. Comito, M. Calvani, E. Giannoni, R. Bianchini, L. Calorini, E. Torre, C. Migliore, S. Giordano, P. Chiarugi HIF-1α stailization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells Free Radic Biol Med 51 2011 893 904
55. Y. Xu, Q. Li, X.Y. Li, Q.Y. Yang, W.W. Xu, G.L. Liu Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis J Exp Clin Cancer Res 31 2012 16
56. J.M. Ebos, C.R. Lee, W. Cruz-Munoz, G.A. Bjarnason, J.G. Christensen, R.S. Kerbel Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis Cancer Cell 15 2009 232 239
57. G. Bergers, D. Hanahan Modes of resistance to anti-angiogenic therapy Nat Rev Cancer 8 2008 592 603
58. S.J. Conley, E. Gheordunescu, P. Kakarala, B. Newman, H. Korkaya, A.N. Heath, S.G. Clouthier, M.S. Wicha Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia Proc Natl Acad Sci USA 109 2012 2784 2789
59. Y. Soda, T. Marumoto, D. Friedmann-Morvinski, M. Soda, F. Liu, H. Michiue, S. Pastorino, M. Yang, R.M. Hoffman, S. Kesari, I.M. Verma Transdifferentiation of glioblastoma cells into vascular endothelial cells Proc Natl Acad Sci USA 108 2011 4274 4280
60. Y.W.J. Paulis, D. Dinnes, P.M.M.B. Soetekouw, P.J. Nelson, S. Burdach, R.P. Loewe, V.C.G. Tjan-Heijnen, I.V. Luettichau, A.W. Griffioen Imatinib reduces the vasculogenic potential of plastic tumor cells Current Angiogenesis 1 2012 64 71
61. S. Zhang, M. Li, Y. Gu, Z. Liu, S. Xu, Y. Cui, B. Sun Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma J Exp Clin Cancer Res 27 2008 60
62. D.W. van der Schaft, R.E.B. Seftor, E.A. Seftor, A.R. Hess, L.M. Gruman, D.A. Kirschmann, Y. Yokoyama, A.W. Griffioen, M.J.C. Hendrix Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells J Natl Cancer Inst 96 2004 1473 1477 (Pubitemid 39429672)
63. Z. Liu, Y. Li, W. Zhao, Y. Ma, X. Yang Demonstration of vasculogenic mimicry in astrocytomas and effects of Endostar on U251 cells Pathol Res Pract 207 2011 645 651
64. M. Su, Y.J. Feng, L.Q. Yao, M.J. Cheng, C.J. Xu, Y. Huang, Y.Q. Zhao, H. Jiang Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo Int J Gynecol Cancer 18 2008 476 486 (Pubitemid 351668302)
65. L.X. Chen, Y.J. He, S.Z. Zhao, J.G. Wu, J.T. Wang, L.M. Zhu, T.T. Lin, B.C. Sun, X.R. Li Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model Cancer Biol Ther 11 2011 229 235
66. A. Serwe, K. Rudolph, T. Anke, G. Erkel Inhibition of TGF-beta signaling, vasculogenic mimicry and proinflammatory gene expression by isoxanthohumol Invest New Drugs 30 2012 898 915
67. L. Zhao, E.S. Marshall, L.R. Kelland, B.C. Baguley Evidence for the involvement of p38 MAP kinase in the action of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) Invest New Drugs 25 2007 271 276 (Pubitemid 46774703)
68. J. Ridgway, G. Zhang, Y. Wu, S. Stawicki, W.C. Liang, Y. Chanthery, J. Kowalski, R.J. Watts, C. Callahan, I. Kasman, M. Singh, M. Chien, C. Tan, J.A. Hongo, F. de Sauvage, G. Plowman, M. Yan Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis Nature 444 2006 1083 1087 (Pubitemid 46018529)
69. J.L. Li, R.C. Sainson, C.E. Oon, H. Turley, R. Leek, H. Sheldon, E. Bridges, W. Shi, C. Snell, E.T. Bowden, H. Wu, P.S. Chowdhury, A.J. Russell, C.P. Montgomery, R. Poulsom, A.L. Harris DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo Cancer Res 71 2011 6073 6083.